Navigation Links
MedQuist Names Alan J. Gold as Senior Vice President, Sales and Marketing
Date:4/3/2009

MOUNT LAUREL, N.J., April 3 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ) has announced it has named Alan J. Gold as its new Senior Vice President of Sales and Marketing. Gold will be responsible for client relationships, new business development, and the positioning and promotion of MedQuist.

"We are pleased to have Alan join the MedQuist team," says Peter Masanotti, President and CEO. "He brings an extensive knowledge and an in-depth understanding of healthcare to our business, along with a fine reputation for fostering world-class executive relationships."

Gold has more than 33 years of experience in the healthcare industry. Most recently, he was the Vice President Sales, Managed Services for Siemens Medical Solutions. During his tenure at Siemens, he was instrumental in growing the business, increasing the volume of customers and improving customer satisfaction. Before joining Siemens, Gold held various sales and marketing executive and leadership positions at Shared Medical Systems (SMS), and was heavily involved in the expansion of SMS before it was acquired by Siemens.

Gold holds a bachelor's degree from Franklin and Marshall College in Lancaster, Pennsylvania, and a Masters of Public Administration from the University of Pittsburgh.

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions - including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors - help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Re-launches New, Improved Web Site
2. MedQuist Updates Status of Outstanding SEC Filings
3. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
4. MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
5. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
6. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
7. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
8. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
9. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
10. MedQuist to Get New Majority Stakeholder
11. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Swirl: A Wine Tasting Event in New York City, with long-time partners The ...
(Date:12/4/2016)... ... ... While James Earl Jones is known for myriad roles on stage and ... Page". One of the forthcoming episodes examines mammogram techniques; a very important part of ... due to early detection. Like any other disease, treatments have a much higher chance ...
(Date:12/4/2016)... , ... December 03, 2016 , ... ... growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual ... Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded ...
(Date:12/4/2016)... Newport Beach, CA (PRWEB) , ... December 04, ... ... youthful appearance without undergoing major cosmetic surgery can now take advantage of a ... is an advanced skin rejuvenation treatment that reduces the appearance of age spots, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... Blueprint Medicines Corporation (NASDAQ: BPMC ... kinase medicines for patients with genomically defined diseases, ... trial evaluating BLU-285, an investigational medicine for the ... Blueprint Medicines is developing BLU-285 as a potent, ... 90 to 95 percent of patients with SM ...
(Date:12/4/2016)... HANOVER, N.J. , Dec. 3, 2016  Results ... (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the median ... 45.3% compared to placebo (1.63 vs 2.98, p=0.010) in ... today announced that the data are being featured in ... American Society of Hematology (ASH) Annual Meeting and presented ...
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test para el mercado africano ... Continue Reading ... New: INSTI Self Test! (PRNewsFoto/bioLytical ... bioLytical Laboratories (la "Compañía"), un líder mundial en ... de su INSTI HIV Self Test  a África con una versión de menor ...
Breaking Medicine Technology: